# The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.

> **NCT03367663** · EARLY_PHASE1 · COMPLETED · sponsor: **Prof. Tony hayek MD** · enrollment: 10 (actual)

## Conditions studied

- Atherosclerosis
- Dyslipidemias
- Diabetes

## Interventions

- **DRUG:** Prednisone 20 Mg
- **DRUG:** Prednisone 40 Mg

## Key facts

- **NCT ID:** NCT03367663
- **Lead sponsor:** Prof. Tony hayek MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-17
- **Primary completion:** 2018-07-09
- **Final completion:** 2018-09-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367663, "The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03367663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
